$0.82
1.22% yesterday
Nasdaq, Mar 11, 09:00 pm CET
ISIN
US09075X1081
Symbol
BDSX

Biodesix Inc Stock price

$0.82
-0.13 14.12% 1M
-0.97 54.41% 6M
-0.71 46.66% YTD
-0.70 46.31% 1Y
-1.42 63.57% 3Y
-11.99 93.63% 5Y
-11.99 93.63% 10Y
Nasdaq, Closing price Tue, Mar 11 2025
+0.01 1.22%
ISIN
US09075X1081
Symbol
BDSX
Sector

Key metrics

Market capitalization $119.13m
Enterprise Value $154.76m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.17
P/S ratio (TTM) P/S ratio 1.67
P/B ratio (TTM) P/B ratio 5.69
Revenue growth (TTM) Revenue growth 45.30%
Revenue (TTM) Revenue $71.32m
EBIT (operating result TTM) EBIT $-34.26m
Free Cash Flow (TTM) Free Cash Flow $-51.92m
Cash position $26.35m
EPS (TTM) EPS $-0.35
P/E forward negative
P/S forward 1.28
EV/Sales forward 1.66
Short interest 0.85%
Show more

Is Biodesix Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,814 stocks worldwide.

Biodesix Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Biodesix Inc forecast:

6x Buy
100%

Analyst Opinions

6 Analysts have issued a Biodesix Inc forecast:

Buy
100%

Financial data from Biodesix Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
71 71
45% 45%
100%
- Direct Costs 16 16
20% 20%
22%
56 56
55% 55%
78%
- Selling and Administrative Expenses 75 75
20% 20%
105%
- Research and Development Expense 9.56 9.56
4% 4%
13%
-29 -29
21% 21%
-40%
- Depreciation and Amortization 5.46 5.46
15% 15%
8%
EBIT (Operating Income) EBIT -34 -34
17% 17%
-48%
Net Profit -43 -43
18% 18%
-60%

In millions USD.

Don't miss a Thing! We will send you all news about Biodesix Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Biodesix Inc Stock News

Neutral
Seeking Alpha
8 days ago
Biodesix, Inc. (NASDAQ:BDSX ) Q4 2024 Earnings Conference Call March 3, 2025 4:30 PM ET Company Participants Chris Brinzey - Investor Relations Scott Hutton - Chief Executive Officer Robin Harper Cowie - Chief Financial Officer Conference Call Participants Andrew Brackmann - William Blair Kyle Mikson - Canaccord Dan Brennan - TD Cowen Thomas Flaten - Lake Street Capital Markets William Bonello ...
Neutral
GlobeNewsWire
8 days ago
Total Revenue of $71.3 million for FY2024, growing 45% over FY2023; Gross margins of 78% for FY2024, up 5% points over FY2023 ; FY2025 Total Revenue Guidance of $92-95 million; Conference Call and Webcast Today at 4:30 p.m. ET LOUISVILLE, Colo.
Neutral
GlobeNewsWire
14 days ago
BOULDER, Colo., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced Scott Hutton, Chief Executive Officer, and Robin Cowie, Chief Financial Officer, will present in a fireside chat and host in-person 1x1 investor meetings at TD Cowen 45th Annual Health Care Conference on March 5, 2025.
More Biodesix Inc News

Company Profile

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. It offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer; and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It is a data-driven diagnostic solutions company with proprietary AI platform to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus in lung disease. The firm offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. . The company was founded in 2005 and is headquartered in Boulder, CO.

Head office United States
CEO Scott Hutton
Employees 273
Founded 2005
Website www.biodesix.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today